FDA approval of revumenib for r/r KMT2Ar AML patients drives strong revenue growth for Syndax Pharmaceuticals, with Q2 2025 sales up 43% quarter-over-quarter. Upcoming FDA Priority Review decision for ...
In patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (CRC) who received immune checkpoint inhibitors, changes in circulating tumor DNA ...
Phase diagram of CO 2 fluid under temperature–pressure combinations, with the triple point and critical point marked. The authors also highlight the degradation of cement in geological CO 2 storage ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced positive topline results from the STELLAR-303 phase 3 pivotal trial in which zanzalintinib in combination with ...
Durability follow-up data of the single-arm cohort in first-line KRAS G12C-mutant non-small cell lung cancer (NSCLC) patients, regardless of PD-L1 expression, who received ifebemtinib + garsorasib ...
An outreach program at Oakland-based Kaiser Permanente Northern California more than doubled colorectal cancer screening rates in almost 20 years, from 37.4% in 2000 to 79.8% in 2019. The research, ...
The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients with advanced colorectal cancer who were treated with an epidermal growth ...
Water is an excellent coolant, but the flip side is that it is also an excellent solvent. This, in short, is why any water cooling loop is also a prime candidate for an interesting introduction to the ...
A Prescription Drug User Fee Act target date of December 12, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the Biologics License Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback